Forsknings- og innovasjonsprosjekter innenfor antimikrobiell resistens i et én-helse perspektiv

Forsknings- og innovasjonsprosjekter innenfor antimikrobiell resistens i et én-helse perspektiv (Research and innovation projects on antimicrobial resistance in a one-health perspective) funds "innovative og kostnadseffektive behandlingsalternativer" (innovative and cost-effective treatment alternatives). Focus areas include developing new antimicrobial agents and treatment protocols, improving clinical effectiveness of current treatments, identifying barriers to access and quality, and assessing economic incentives and regulations affecting drug development and supply.

Eligible applicants include public sector entities, businesses/industry, and research organisations ("Offentlig sektor, Næringsliv, Forskningsorganisasjon"). SMEs and industry partners receive up to 50% of qualified project costs.

The call is part of the European Partnership on One Health Antimicrobial Resistance (EUP OHAMR). Norges forskningsråd contributes "ca 1 000 000 Euro" to the call. Individual applicants may request "ca 300 000 - 400 000 Euro" depending on whether they act as coordinator. The total call budget across all funders is stated as "ca 35 mill. Euro."

The call window opens 2 February 2026 at 00:00 CET and closes 17 June 2026 at 00:00 CEST. Call details are available at https://ohamr.eu/call-2025-new-treatments-to-tackle-amr/. The page was last updated 20 October 2025.